These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 17051427)

  • 1. Tumor characteristics and detection method in the MRISC screening program for the early detection of hereditary breast cancer.
    Kriege M; Brekelmans CT; Peterse H; Obdeijn IM; Boetes C; Zonderland HM; Muller SH; Kok T; Manoliu RA; Besnard AP; Tilanus-Linthorst MM; Seynaeve C; Bartels CC; Meijer S; Oosterwijk JC; Hoogerbrugge N; Tollenaar RA; de Koning HJ; Rutgers EJ; Klijn JG
    Breast Cancer Res Treat; 2007 May; 102(3):357-63. PubMed ID: 17051427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences between first and subsequent rounds of the MRISC breast cancer screening program for women with a familial or genetic predisposition.
    Kriege M; Brekelmans CT; Boetes C; Muller SH; Zonderland HM; Obdeijn IM; Manoliu RA; Kok T; Rutgers EJ; de Koning HJ; Klijn JG;
    Cancer; 2006 Jun; 106(11):2318-26. PubMed ID: 16615112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors affecting sensitivity and specificity of screening mammography and MRI in women with an inherited risk for breast cancer.
    Kriege M; Brekelmans CT; Obdeijn IM; Boetes C; Zonderland HM; Muller SH; Kok T; Manoliu RA; Besnard AP; Tilanus-Linthorst MM; Seynaeve C; Bartels CC; Kaas R; Meijer S; Oosterwijk JC; Hoogerbrugge N; Tollenaar RA; Rutgers EJ; de Koning HJ; Klijn JG
    Breast Cancer Res Treat; 2006 Nov; 100(1):109-19. PubMed ID: 16791481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imaging.
    Saadatmand S; Tilanus-Linthorst MM; Rutgers EJ; Hoogerbrugge N; Oosterwijk JC; Tollenaar RA; Hooning M; Loo CE; Obdeijn IM; Heijnsdijk EA; de Koning HJ
    J Natl Cancer Inst; 2013 Sep; 105(17):1314-21. PubMed ID: 23940285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition.
    Kriege M; Brekelmans CT; Boetes C; Besnard PE; Zonderland HM; Obdeijn IM; Manoliu RA; Kok T; Peterse H; Tilanus-Linthorst MM; Muller SH; Meijer S; Oosterwijk JC; Beex LV; Tollenaar RA; de Koning HJ; Rutgers EJ; Klijn JG;
    N Engl J Med; 2004 Jul; 351(5):427-37. PubMed ID: 15282350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival benefit in women with BRCA1 mutation or familial risk in the MRI screening study (MRISC).
    Saadatmand S; Obdeijn IM; Rutgers EJ; Oosterwijk JC; Tollenaar RA; Woldringh GH; Bergers E; Verhoef C; Heijnsdijk EA; Hooning MJ; de Koning HJ; Tilanus-Linthorst MM
    Int J Cancer; 2015 Oct; 137(7):1729-38. PubMed ID: 25820931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of false-negative cases of breast MR imaging in women with a familial or genetic predisposition.
    Obdeijn IM; Loo CE; Rijnsburger AJ; Wasser MN; Bergers E; Kok T; Klijn JG; Boetes C
    Breast Cancer Res Treat; 2010 Jan; 119(2):399-407. PubMed ID: 19876732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination.
    Warner E; Plewes DB; Hill KA; Causer PA; Zubovits JT; Jong RA; Cutrara MR; DeBoer G; Yaffe MJ; Messner SJ; Meschino WS; Piron CA; Narod SA
    JAMA; 2004 Sep; 292(11):1317-25. PubMed ID: 15367553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of clinical breast examination to mammography screening in the early detection of breast cancer.
    Bancej C; Decker K; Chiarelli A; Harrison M; Turner D; Brisson J
    J Med Screen; 2003; 10(1):16-21. PubMed ID: 12790311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective multicenter cohort study to refine management recommendations for women at elevated familial risk of breast cancer: the EVA trial.
    Kuhl C; Weigel S; Schrading S; Arand B; Bieling H; König R; Tombach B; Leutner C; Rieber-Brambs A; Nordhoff D; Heindel W; Reiser M; Schild HH
    J Clin Oncol; 2010 Mar; 28(9):1450-7. PubMed ID: 20177029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and self breast examination remain important in the era of modern screening.
    Ma I; Dueck A; Gray R; Wasif N; Giurescu M; Lorans R; Pizzitola V; Pockaj B
    Ann Surg Oncol; 2012 May; 19(5):1484-90. PubMed ID: 22160521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First experiences in screening women at high risk for breast cancer with MR imaging.
    Tilanus-Linthorst MM; Obdeijn IM; Bartels KC; de Koning HJ; Oudkerk M
    Breast Cancer Res Treat; 2000 Sep; 63(1):53-60. PubMed ID: 11079159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should we screen BRCA1 mutation carriers only with MRI? A multicenter study.
    Obdeijn IM; Winter-Warnars GA; Mann RM; Hooning MJ; Hunink MG; Tilanus-Linthorst MM
    Breast Cancer Res Treat; 2014 Apr; 144(3):577-82. PubMed ID: 24567197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Axillary node dissection in patients with breast cancer diagnosed through the Ontario Breast Screening Program: a need for minimally invasive techniques.
    Singhal H; O'Malley FP; Tweedie E; Stitt L; Tonkin KS
    Can J Surg; 1997 Oct; 40(5):377-82. PubMed ID: 9336528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systematic review of the effectiveness of magnetic resonance imaging (MRI) as an addition to mammography and ultrasound in screening young women at high risk of breast cancer.
    Lord SJ; Lei W; Craft P; Cawson JN; Morris I; Walleser S; Griffiths A; Parker S; Houssami N
    Eur J Cancer; 2007 Sep; 43(13):1905-17. PubMed ID: 17681781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Invasive cancers detected after breast cancer screening yielded a negative result: relationship of mammographic density to tumor prognostic factors.
    Roubidoux MA; Bailey JE; Wray LA; Helvie MA
    Radiology; 2004 Jan; 230(1):42-8. PubMed ID: 14695385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surveillance of women at increased risk of breast cancer using mammography and clinical breast examination: further evidence of benefit.
    Maurice A; Evans DG; Affen J; Greenhalgh R; Duffy SW; Howell A
    Int J Cancer; 2012 Jul; 131(2):417-25. PubMed ID: 21898384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer.
    Kuhl CK; Schrading S; Leutner CC; Morakkabati-Spitz N; Wardelmann E; Fimmers R; Kuhn W; Schild HH
    J Clin Oncol; 2005 Nov; 23(33):8469-76. PubMed ID: 16293877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of detection method in predicting breast cancer survival: analysis of randomized screening trials.
    Shen Y; Yang Y; Inoue LY; Munsell MF; Miller AB; Berry DA
    J Natl Cancer Inst; 2005 Aug; 97(16):1195-203. PubMed ID: 16106024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetic resonance imaging and mammography in women with a hereditary risk of breast cancer.
    Stoutjesdijk MJ; Boetes C; Jager GJ; Beex L; Bult P; Hendriks JH; Laheij RJ; Massuger L; van Die LE; Wobbes T; Barentsz JO
    J Natl Cancer Inst; 2001 Jul; 93(14):1095-102. PubMed ID: 11459871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.